Unknown Author
2 min
Parkinson’s disease is a progressive neurodegenerative disorder that significantly impacts global health. Clinically, it is defined by motor symptoms such as tremor and bradykinesia (slowness of movement). As the global population ages, the prevalence of the disease is rising, placing an increasing burden on healthcare systems and individual productivity. Because the disease shares symptoms with various other extrapyramidal conditions, accurate diagnosis remains a primary clinical challenge.
Unlike many other neurodegenerative conditions, idiopathic Parkinson’s disease is unique in that it has well-established, effective treatment options. The primary approach to management involves pharmacologic intervention using antiparkinson agents, which are highly effective at mitigating symptoms and improving a patient's day-to-day functional capacity.
For patients who do not experience sustained benefits from medication or who suffer from significant side effects, the paper highlights the role of surgical interventions, specifically deep brain stimulation (DBS). These treatments are instrumental in enhancing the quality of life for those living with the disease.
This paper serves as a clinical review of the current landscape regarding Parkinson’s disease. By emphasizing the importance of differential diagnosis—distinguishing Parkinson’s from other similar movement disorders—the authors underscore the necessity of precise clinical evaluation. The study highlights that while the disease is progressive and age-related, the availability of both medical and surgical therapies provides a pathway to manage symptoms effectively. Understanding these treatment modalities is essential for clinicians and researchers aiming to optimize patient outcomes in the face of an aging population.